Author Question: Realistic short-term goals for a patient who is newly admitted to the hospital should be achievable ... (Read 38 times)

D2AR0N

  • Hero Member
  • *****
  • Posts: 561
Realistic short-term goals for a patient who is newly admitted to the hospital should be achievable in
 
  a. 1 to 2 days.
  b. 4 to 6 days.
  c. 1 to 2 weeks.
  d. 2 to 4 weeks.

Question 2

Which third-generation antipsychotic medication acts by stabilizing the dopamine system?
 
  a. Aripiprazole (Abilify)
  b. Ziprasicone (Geodon)
  c. Quetiapine (Seroquel)
  d. Risperidone (Risperdal)



succesfull

  • Sr. Member
  • ****
  • Posts: 339
Answer to Question 1

B
Short-term goals are those achievable in 4 to 6 days for hospitalized patients and somewhat longer for patients in other settings. A period of 1 to 2 days allows too little time. The other options suggest longer times than necessary.

Answer to Question 2

A
Aripiprazole is novel in action. It acts by stabilizing the dopamine system through partial agonism of dopamine D2 and 5-HT2 . The other drugs are atypical antipsychotics, which have other modes of action that produce therapeutic effects.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Many people have small pouches in their colons that bulge outward through weak spots. Each pouch is called a diverticulum. About 10% of Americans older than age 40 years have diverticulosis, which, when the pouches become infected or inflamed, is called diverticulitis. The main cause of diverticular disease is a low-fiber diet.

Did you know?

In Eastern Europe and Russia, interferon is administered intranasally in varied doses for the common cold and influenza. It is claimed that this treatment can lower the risk of infection by as much as 60–70%.

Did you know?

Eat fiber! A diet high in fiber can help lower cholesterol levels by as much as 10%.

Did you know?

The strongest synthetic topical retinoid drug available, tazarotene, is used to treat sun-damaged skin, acne, and psoriasis.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library